Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH): A Real World, Prospective and Retrospective, Observational Study

NCT07447648 is registered in ClinicalTrials.gov with Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) as lead sponsor.

NCT NCT07447648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07447648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH): A Real World, Prospective and Retrospective, Observational Study
Lead sponsor
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Phase
Observational
Overall status
Recruiting
Start date
April 30, 2026
Completion date
February 28, 2029
Enrollment
52 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

coronary computed tomography angiography, homozygous familial hypercholesterolemia (hofh)